Novozymes A/S (OTCMKTS:NVZMY) Shares Cross Below Fifty Day Moving Average - Should You Sell?

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report)'s stock price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $60.70 and traded as low as $56.00. Novozymes A/S shares last traded at $56.00, with a volume of 17,470 shares traded.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on NVZMY. Berenberg Bank upgraded Novozymes A/S to a "strong-buy" rating in a report on Tuesday, September 24th. Citigroup cut shares of Novozymes A/S from a "neutral" rating to a "sell" rating in a report on Thursday, October 17th. Finally, Barclays upgraded shares of Novozymes A/S to a "strong-buy" rating in a report on Monday, November 18th.

Novozymes A/S Stock Up 1.1 %

The company has a fifty day moving average price of $60.48 and a two-hundred day moving average price of $63.35. The firm has a market capitalization of $26.51 billion, a price-to-earnings ratio of 35.83, a P/E/G ratio of 3.87 and a beta of 0.87.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.